KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $213.9 million.

  • Globus Medical's Free Cash Flow rose 3226.68% to $213.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $579.6 million, marking a year-over-year increase of 9729.66%. This contributed to the annual value of $405.2 million for FY2024, which is 14524.68% up from last year.
  • According to the latest figures from Q3 2025, Globus Medical's Free Cash Flow is $213.9 million, which was up 3226.68% from $31.3 million recorded in Q2 2025.
  • Over the past 5 years, Globus Medical's Free Cash Flow peaked at $213.9 million during Q3 2025, and registered a low of $13.1 million during Q2 2022.
  • Moreover, its 5-year median value for Free Cash Flow was $45.6 million (2022), whereas its average is $67.4 million.
  • In the last 5 years, Globus Medical's Free Cash Flow plummeted by 7415.51% in 2022 and then soared by 49279.15% in 2025.
  • Quarter analysis of 5 years shows Globus Medical's Free Cash Flow stood at $59.2 million in 2021, then decreased by 22.92% to $45.6 million in 2022, then surged by 79.23% to $81.8 million in 2023, then soared by 136.24% to $193.2 million in 2024, then grew by 10.69% to $213.9 million in 2025.
  • Its Free Cash Flow was $213.9 million in Q3 2025, compared to $31.3 million in Q2 2025 and $141.2 million in Q1 2025.